Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Sigilon Therapeutics, Inc. SGTX

Set alert

Price alert · SGTX

All alert types
22.47 +22.47 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
53.57M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-1.66
Beta
4.17
Short ratio
0.76
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2023
50-d avg
8.55
200-d avg
8.23
1y target
47.33

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SGTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-6.57 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.4×
FY 2018: -24.0×FY 2019: -16.4×FY 2020: -27.5×FY 2021: -1.1×FY 2022: -3.4×
FY 2018 5y median -16.4× FY 2022
P/S 11.4×
FY 2018: 118×FY 2019: 51.7×FY 2020: 113×FY 2021: 9.2×FY 2022: 11.4×
FY 2018 5y median 51.7× FY 2022
P/B 3.8×
FY 2018: -15.1×FY 2019: -9.4×FY 2020: 10.3×FY 2021: 1.1×FY 2022: 3.8×
FY 2018 5y median 1.1× FY 2022
P/FCF -2.8×
FY 2018: 14.9×FY 2019: -14.3×FY 2020: -24.1×FY 2021: -1.1×FY 2022: -2.8×
FY 2018 5y median -2.8× FY 2022
EV/EBITDA -3.3×
FY 2018: -22.1×FY 2019: -16.0×FY 2020: -25.6×FY 2021: -0.2×FY 2022: -3.3×
FY 2018 5y median -16.0× FY 2022
EV/Sales 10.3×
FY 2018: 105×FY 2019: 48.1×FY 2020: 101×FY 2021: 1.5×FY 2022: 10.3×
FY 2018 5y median 48.1× FY 2022
FCF Yield -35.3%
FY 2018: 6.7%FY 2019: -7.0%FY 2020: -4.1%FY 2021: -91.2%FY 2022: -35.3%
FY 2018 5y median -7.0% FY 2022

Profitability

Gross Margin 100.0%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%
FY 2018 5y median 100.0% FY 2022
Operating Margin -337.3%
FY 2018: -497.6%FY 2019: -311.7%FY 2020: -393.6%FY 2021: -788.0%FY 2022: -337.3%
FY 2018 5y median -393.6% FY 2022
Net Margin -335.7%
FY 2018: -490.9%FY 2019: -314.9%FY 2020: -410.3%FY 2021: -815.0%FY 2022: -335.7%
FY 2018 5y median -410.3% FY 2022
ROE -111.0%
FY 2018: 63.1%FY 2019: 57.3%FY 2020: -37.5%FY 2021: -101.4%FY 2022: -111.0%
FY 2018 5y median -37.5% FY 2022
ROIC -64.6%
FY 2018: -59.0%FY 2019: -82.7%FY 2020: -28.7%FY 2021: -65.2%FY 2022: -64.6%
FY 2018 5y median -64.6% FY 2022
ROA -49.8%
FY 2018: -33.6%FY 2019: -49.3%FY 2020: -24.4%FY 2021: -54.2%FY 2022: -49.8%
FY 2018 5y median -49.3% FY 2022

Growth (YoY)

Revenue 34.8%
FY 2018: 0.0%FY 2019: 205.3%FY 2020: -5.5%FY 2021: -28.2%FY 2022: 34.8%
FY 2018 FY 2022
Operating Income 42.3%
FY 2018: 0.0%FY 2019: -91.2%FY 2020: -19.3%FY 2021: -43.7%FY 2022: 42.3%
FY 2018 FY 2022
EPS (diluted) 95.8%
FY 2018: 0.0%FY 2019: -46.0%FY 2020: 17.7%FY 2021: -40.8%FY 2022: 95.8%
FY 2018 FY 2022
Free Cash Flow 35.2%
FY 2018: 0.0%FY 2019: -239.8%FY 2020: -22.1%FY 2021: -28.1%FY 2022: 35.2%
FY 2018 FY 2022

Financial Health

Current Ratio 2.4×
FY 2018: 2.2×FY 2019: 1.9×FY 2020: 4.3×FY 2021: 3.6×FY 2022: 2.4×
FY 2018 5y median 2.4× FY 2022
Quick Ratio 2.4×
FY 2018: 2.2×FY 2019: 1.9×FY 2020: 4.3×FY 2021: 3.6×FY 2022: 2.4×
FY 2018 5y median 2.4× FY 2022
Debt / Equity 0.7×
FY 2018: -0.1×FY 2019: -0.3×FY 2020: 0.3×FY 2021: 0.4×FY 2022: 0.7×
FY 2018 5y median 0.3× FY 2022
Net Debt / EBITDA 0.4×
FY 2018: 2.7×FY 2019: 1.2×FY 2020: 3.1×FY 2021: 1.0×FY 2022: 0.4×
FY 2018 5y median 1.2× FY 2022
Interest Coverage -19.1×
FY 2018: -79.8×FY 2019: -67.9×FY 2020: -43.8×FY 2021: -38.0×FY 2022: -19.1×
FY 2018 5y median -43.8× FY 2022

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31